
Conference Coverage
17 days ago
Hernexeos Effective in HER2-Mutated NSCLCLatest Content

Shorts






Podcasts
Videos
All News

MB-105 received a special FDA status to help deliver faster treatment options for people with relapsed T-cell lymphoma who have few options.

Four-time non-Hodgkin lymphoma survivor Shell Rowe knows very well about the importance of finding the lighthearted side of an otherwise serious situation.

While cancer patients can experience ghosting, and cancer ghosting is real, it is possible to revisit relationships to avoid putting blaming the person who appears to be slipping away.

Dave Nitsche, a nonsmoker and endurance athlete, pushes back against stigma and stays active while advocating for lung cancer screening.

Experts highlight perioperative Padcev plus Keytruda in bladder cancer, showing potential practice-changing results from ESMO 2025 for patients.

I’ve learned that social media can unite people at hereditary cancer risk but often leaves diverse voices out, so real change means every story is seen and valued.

The artwork of Gail Durant, winner of the annual CURE Calendar Contest, captured the heart of her family’s connection to home and the cancer journey.

For some with GIST, bezuclastinib plus Sutent led to longer progression-free survival and higher response rates compared with Sutent alone.

In recognition of Pancreatic Cancer Awareness Month, Dr. Suneel Kamath sat down for an interview where he shared his insights on this aggressive disease.

Thymoma is a rare cancer of the thymus that can be treated with surgery, radiation, chemotherapy or immunotherapy depending on stage.

Understand your stage 2 oral cavity cancer diagnosis, explore primary treatment options and get key questions for your oncologist.

These are the basics of bile duct cancer, from diagnosis to treatment.

This guide provides an overview of stage 2 uterine (endometrial) cancer, including diagnosis, treatment options, and common side effects. A cancer diagnosis is life-changing, and it is natural to feel

October brought developments in the management of blood cancers, from early-stage multiple myeloma to new cellular therapies and novel drug designations.

Dr. Mariano Provencio says many patients still face recurrence after lung cancer surgery and perioperative treatment aims to improve survival.


























